158 related articles for article (PubMed ID: 34389530)
1. The efficacy and safety of 5-fluorouracil based adjuvant therapy in resected biliary tract cancer: A systematic review and meta-analysis.
Song S; Yang W; Tian H; Gong S; Lei C; Lv K; Lu T; Cheng Q; Yang K; Guo T
Clin Res Hepatol Gastroenterol; 2022 Feb; 46(2):101788. PubMed ID: 34389530
[TBL] [Abstract][Full Text] [Related]
2. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
[TBL] [Abstract][Full Text] [Related]
3. A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01).
Itano O; Takemura Y; Kishida N; Tamagawa E; Shinozaki H; Ikeda K; Urakami H; Ei S; Hayatsu S; Suzuki K; Sakuragawa T; Ishii M; Shito M; Aiura K; Fujisaki H; Takano K; Matsui J; Minagawa T; Shinoda M; Kitago M; Abe Y; Yagi H; Oshima G; Hori S; Kitagawa Y
BMC Cancer; 2020 Jul; 20(1):688. PubMed ID: 32703191
[TBL] [Abstract][Full Text] [Related]
4. Effect of Adjuvant Gemcitabine Combined with Low-dose 5-Fluorouracil and Cisplatin Chemotherapy for Advanced Biliary Carcinoma.
Morine Y; Shimada M; Ikemoto T; Arakawa Y; Iwahashi S; Saito YU; Yamada S; Imura S
Anticancer Res; 2017 Nov; 37(11):6421-6428. PubMed ID: 29061828
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy in resected bile duct cancer: A systematic review and meta-analysis of randomized trials.
Messina C; Merz V; Frisinghelli M; Trentin C; Grego E; Veccia A; Salati M; Messina M; Carnaghi C; Caffo O
Crit Rev Oncol Hematol; 2019 Nov; 143():124-129. PubMed ID: 31563828
[TBL] [Abstract][Full Text] [Related]
6. Surgical Resection Alone is Associated With Higher Long-Term Survival Than Multiagent Chemotherapy Alone for Patients With Localized Biliary Tract Cancers.
Elshami M; Ammori JB; Hardacre JM; Selfridge JE; Bajor D; Mohamed A; Chakrabarti S; Mahipal A; Winter JM; Ocuin LM
J Surg Res; 2024 Mar; 295():705-716. PubMed ID: 38141457
[TBL] [Abstract][Full Text] [Related]
7. Current standards and future perspectives in adjuvant treatment for biliary tract cancers.
Lamarca A; Edeline J; McNamara MG; Hubner RA; Nagino M; Bridgewater J; Primrose J; Valle JW
Cancer Treat Rev; 2020 Mar; 84():101936. PubMed ID: 31986437
[TBL] [Abstract][Full Text] [Related]
8. Trends in Receipt of Adjuvant Chemotherapy and its Impact on Survival in Resected Biliary Tract Cancers.
Rhodin KE; Liu A; Bartholomew A; Kramer R; Parameswaran A; Uronis H; Strickler J; Hsu D; Morse MA; Shah KN; Herbert G; Zani S; Nussbaum DP; Allen PJ; Lidsky ME
Ann Surg Oncol; 2023 Aug; 30(8):4813-4821. PubMed ID: 37188803
[TBL] [Abstract][Full Text] [Related]
9. Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.
Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Kim HB; Hong EK; Park JW; Kim CM
Chemotherapy; 2012; 58(3):225-32. PubMed ID: 22831988
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis.
Ghidini M; Tomasello G; Botticelli A; Barni S; Zabbialini G; Seghezzi S; Passalacqua R; Braconi C; Petrelli F
HPB (Oxford); 2017 Sep; 19(9):741-748. PubMed ID: 28684194
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of randomized clinical trials of adjuvant chemotherapy for resected biliary tract cancers.
Ma WJ; Jin YW; Wu ZR; Yang Q; Wang JK; Liu F; Shi YJ; Li QS; Cheng NS
HPB (Oxford); 2020 Jul; 22(7):939-949. PubMed ID: 32349925
[TBL] [Abstract][Full Text] [Related]
12. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer.
Matull WR; Dhar DK; Ayaru L; Sandanayake NS; Chapman MH; Dias A; Bridgewater J; Webster GJ; Bong JJ; Davidson BR; Pereira SP
Liver Int; 2011 Jan; 31(1):99-107. PubMed ID: 20846273
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
14. Systematic review with network meta-analysis: adjuvant therapy for resected biliary tract cancer.
Zhu GQ; Shi KQ; You J; Zou H; Lin YQ; Wang LR; Braddock M; Chen YP; Zheng MH
Aliment Pharmacol Ther; 2014 Oct; 40(7):759-70. PubMed ID: 25099956
[TBL] [Abstract][Full Text] [Related]
15. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.
Takada T; Amano H; Yasuda H; Nimura Y; Matsushiro T; Kato H; Nagakawa T; Nakayama T;
Cancer; 2002 Oct; 95(8):1685-95. PubMed ID: 12365016
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of adjuvant treatments for patients with resected biliary tract cancer: a systematic review and network meta-analysis.
Chen Y; Zhang B; Liu C; Cao Y; Lyu C; Qiu M
BMJ Open; 2022 Apr; 12(4):e051421. PubMed ID: 35440445
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
[TBL] [Abstract][Full Text] [Related]
18. Prognostic immunohistochemical biomarkers of chemotherapy efficacy in biliary tract cancer: A systematic review and meta-analysis.
Belkouz A; Labeur TA; Dierks J; Dijk F; van Oijen MGH; Verheij J; van Gulik TM; van de Vijver MJ; Wilmink H; Punt CJA; Klümpen HJ
Crit Rev Oncol Hematol; 2019 Sep; 141():82-94. PubMed ID: 31255992
[TBL] [Abstract][Full Text] [Related]
19. Survival outcome of patient with pT1N0 biliary tract cancer treated with surgery alone.
Kagoura M; Kobayashi S; Kojima M; Kudo M; Sugimoto M; Konishi M; Gotohda N
Eur J Surg Oncol; 2024 Mar; 50(3):107980. PubMed ID: 38281442
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis.
Horgan AM; Amir E; Walter T; Knox JJ
J Clin Oncol; 2012 Jun; 30(16):1934-40. PubMed ID: 22529261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]